Eqrx Inc (EQRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EQRX | EVO | COLL | ||
| Company | Eqrx Inc | Evotec Se | Collegium Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.39 | 3.17 | 34.30 | ||
| High | 2.42 | 3.19 | 35.26 | ||
| Low | 2.32 | 3.13 | 34.25 | ||
| Latest | 2.34 | 3.15 | 34.31 | ||
| Change | -0.05 | -0.11 | -0.10 | ||
| % Change | -2.09% | -3.37% | -0.29% | ||
| Volume | 16,554,600 | 87,100 | 344,000 | ||
| 20-Day Average Volume | 4,083,095 | 92,395 | 573,785 | ||
| Previous Close | 2.39 | 3.26 | 34.41 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.26 | 2.70 | 33.76 | ||
| 20-Day Raw Stochastic | 53.66% | 79.90% | 52.96% | ||
| 20-Day Relative Strength | 55.03 | 58.15 | 42.52 | ||
| Weighted Alpha | -18.40 | -17.06 | +10.67 | ||
| Today's Opinion | 96% Buy | 40% Sell | 72% Sell | ||
| Previous Opinion | 96% Buy | 40% Sell | 72% Sell | ||
| Last Month's Opinion | 24% Buy | 88% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.54% since 11/01/23 | +13.31% since 04/13/26 | -3.68% since 04/13/26 | ||
| Low | 2.23 on 11/02/23 | 3.04 on 04/14/26 | 32.64 on 04/16/26 | ||
| High | 2.63 on 11/03/23 | 3.36 on 04/17/26 | 36.27 on 04/14/26 | ||
| 1-Month | |||||
| %Chg | +5.41% since 10/06/23 | +29.63% since 03/20/26 | -3.19% since 03/20/26 | ||
| Low | 2.01 on 10/30/23 | 2.34 on 03/24/26 | 31.54 on 04/06/26 | ||
| High | 2.63 on 11/03/23 | 3.36 on 04/17/26 | 36.77 on 03/23/26 | ||
| 3-Month | |||||
| %Chg | +4.46% since 08/08/23 | -7.08% since 01/20/26 | -28.07% since 01/20/26 | ||
| Low | 2.01 on 10/30/23 | 2.31 on 03/13/26 | 31.54 on 04/06/26 | ||
| High | 2.63 on 11/03/23 | 3.82 on 02/03/26 | 49.31 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | +27.17% since 05/08/23 | -19.64% since 10/20/25 | -1.55% since 10/20/25 | ||
| Low | 1.60 on 05/09/23 | 2.31 on 03/13/26 | 31.54 on 04/06/26 | ||
| High | 2.63 on 11/03/23 | 4.27 on 10/27/25 | 50.79 on 12/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,140,551 | 1,158,904 | 1,115,125 | ||
| Shares Outstanding, K | 487,415 | 355,492 | 32,407 | ||
| Annual Sales | 0 | 891,970,000 | 780,570,000 | ||
| Annual Net Income | -169,090,000 | -117,120,000 | 62,870,000 | ||
| Last Quarter Sales | 0 | 295,330,000 | 205,450,000 | ||
| Last Quarter Net Income | -72,960,000 | 15,870,000 | 16,960,000 | ||
| 60-Month Beta | 0.48 | 1.92 | 0.77 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 08/08/23 | N/A | 2.04 on 02/26/26 | ||
| Latest Earnings Date | 11/09/23 | 11/05/25 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 5.00 | ||